BILL NUMBER: SB 493 AMENDED
BILL TEXT
AMENDED IN SENATE MAY 28, 2013
AMENDED IN SENATE APRIL 24, 2013
AMENDED IN SENATE APRIL 1, 2013
INTRODUCED BY Senator Hernandez
FEBRUARY 21, 2013
An act to amend Sections 733, 4050, 4051, 4052, 4052.3, and 4060
of, and to add Sections 4016.5, 4052.6, 4052.8, 4052.9, 4210, and
4233 to, the Business and Professions Code, relating to pharmacy.
LEGISLATIVE COUNSEL'S DIGEST
SB 493, as amended, Hernandez. Pharmacy practice.
The Pharmacy Law provides for the licensing and regulation of
pharmacists by the California State Board of Pharmacy in the
Department of Consumer Affairs. The law specifies the functions
pharmacists are authorized to perform, including to administer,
orally or topically, drugs and biologicals pursuant to a prescriber's
order, and to administer immunizations pursuant to a protocol with a
prescriber. Pharmacists may also furnish emergency contraception
drug therapy pursuant to standardized procedures if they have
completed a training program. A violation of the Pharmacy Law is a
crime.
This bill, instead, would authorize a pharmacist to administer
drugs and biological products that have been ordered by a prescriber.
The bill would expand other functions pharmacists are authorized to
perform, including, among other things, to furnish self-administered
hormonal contraceptives, prescription smoking cessation drugs, and
prescription medications not requiring a diagnosis that are
recommended for international travelers, as specified. Additionally,
the bill would authorize pharmacists to order and interpret tests for
the purpose of monitoring and managing the efficacy and toxicity of
drug therapies, and to independently initiate and administer routine
vaccinations, as specified. This bill also would establish board
recognition for an advanced practice pharmacist, as defined, would
specify the criteria for that recognition, and would specify
additional functions that may be performed by an advanced practice
pharmacist, including, among other things, performing patient
assessments, and certain other functions, as specified. The bill
would authorize the board , by regulation
, to set the fee for the issuance and renewal
of advanced practice pharmacist recognition at the reasonable cost of
regulating advanced practice pharmacists pursuant to these
provisions, not to exceed $300. Because a violation of these
provisions would be a crime, the bill would impose a state-mandated
local program.
The bill would make other conforming and technical changes.
The California Constitution requires the state to reimburse local
agencies and school districts for certain costs mandated by the
state. Statutory provisions establish procedures for making that
reimbursement.
This bill would provide that no reimbursement is required by this
act for a specified reason.
Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: yes.
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:
SECTION 1. Section 733 of the Business and Professions Code is
amended to read:
733. (a) A licentiate shall not obstruct a patient in obtaining a
prescription drug or device that has been legally prescribed or
ordered for that patient. A violation of this section constitutes
unprofessional conduct by the licentiate and shall subject the
licentiate to disciplinary or administrative action by his or her
licensing agency.
(b) Notwithstanding any other law, a licentiate shall dispense
drugs and devices, as described in subdivision (a) of Section 4024,
pursuant to a lawful order or prescription unless one of the
following circumstances exists:
(1) Based solely on the licentiate's professional training and
judgment, dispensing pursuant to the order or the prescription is
contrary to law, or the licentiate determines that the prescribed
drug or device would cause a harmful drug interaction or would
otherwise adversely affect the patient's medical condition.
(2) The prescription drug or device is not in stock. If an order,
other than an order described in Section 4019, or prescription cannot
be dispensed because the drug or device is not in stock, the
licentiate shall take one of the following actions:
(A) Immediately notify the patient and arrange for the drug or
device to be delivered to the site or directly to the patient in a
timely manner.
(B) Promptly transfer the prescription to another pharmacy known
to stock the prescription drug or device that is near enough to the
site from which the prescription or order is transferred, to ensure
the patient has timely access to the drug or device.
(C) Return the prescription to the patient and refer the patient.
The licentiate shall make a reasonable effort to refer the patient to
a pharmacy that stocks the prescription drug or device that is near
enough to the referring site to ensure that the patient has timely
access to the drug or device.
(3) The licentiate refuses on ethical, moral, or religious grounds
to dispense a drug or device pursuant to an order or prescription. A
licentiate may decline to dispense a prescription drug or device on
this basis only if the licentiate has previously notified his or her
employer, in writing, of the drug or class of drugs to which he or
she objects, and the licentiate's employer can, without creating
undue hardship, provide a reasonable accommodation of the licentiate'
s objection. The licentiate's employer shall establish protocols that
ensure that the patient has timely access to the prescribed drug or
device despite the licentiate's refusal to dispense the prescription
or order. For purposes of this section, "reasonable accommodation"
and "undue hardship" shall have the same meaning as applied to those
terms pursuant to subdivision (l) of Section 12940 of the Government
Code.
(c) For the purposes of this section, "prescription drug or device"
has the same meaning as the definition in Section 4022.
(d) This section applies to emergency contraception drug therapy
and self-administered hormonal contraceptives described in Section
4052.3.
(e) This section imposes no duty on a licentiate to dispense a
drug or device pursuant to a prescription or order without payment
for the drug or device, including payment directly by the patient or
through a third-party payer accepted by the licentiate or payment of
any required copayment by the patient.
(f) The notice to consumers required by Section 4122 shall include
a statement that describes patients' rights relative to the
requirements of this section.
SEC. 2. Section 4016.5 is added to the Business and Professions
Code, to read:
4016.5. "Advanced practice pharmacist" means a licensed
pharmacist who has been recognized as an advanced practice pharmacist
by the board, pursuant to Section 4210. A board-recognized advanced
practice pharmacist is entitled to practice advanced practice
pharmacy, as described in Section 4052.6, within or outside of a
licensed pharmacy as authorized by this chapter.
SEC. 3. Section 4050 of the Business and Professions Code is
amended to read:
4050. (a) In recognition of and consistent with the decisions of
the appellate courts of this state, the Legislature hereby declares
the practice of pharmacy to be a profession.
(b) Pharmacy practice is a dynamic, patient-oriented health
service that applies a scientific body of knowledge to improve and
promote patient health by means of appropriate drug use, drug-related
therapy, and communication for clinical and consultative purposes.
Pharmacy practice is continually evolving to include more
sophisticated and comprehensive patient care activities.
(c) The Legislature further declares that pharmacists are health
care providers who have the authority to provide health care
services.
SEC. 4. Section 4051 of the Business and Professions Code is
amended to read:
4051. (a) Except as otherwise provided in this chapter, it is
unlawful for any person to manufacture, compound, furnish, sell, or
dispense a dangerous drug or dangerous device, or to dispense or
compound a prescription pursuant to Section 4040 of a prescriber
unless he or she is a pharmacist under this chapter.
(b) Notwithstanding any other law, a pharmacist may authorize the
initiation of a prescription, pursuant to Section 4052.1, 4052.2,
4052.3, or 4052.6, and otherwise provide clinical advice, services,
information, or patient consultation, as set forth in this chapter,
if all of the following conditions are met:
(1) The clinical advice, services, information, or patient
consultation is provided to a health care professional or to a
patient.
(2) The pharmacist has access to prescription, patient profile, or
other relevant medical information for purposes of patient and
clinical consultation and advice.
(3) Access to the information described in paragraph (2) is secure
from unauthorized access and use.
SEC. 5. Section 4052 of the Business and Professions Code is
amended to read:
4052. (a) Notwithstanding any other law, a pharmacist may:
(1) Furnish a reasonable quantity of compounded drug product to a
prescriber for office use by the prescriber.
(2) Transmit a valid prescription to another pharmacist.
(3) Administer drugs and biological products that have been
ordered by a prescriber.
(4) Perform procedures or functions in a licensed health care
facility as authorized by Section 4052.1.
(5) Perform procedures or functions as part of the care provided
by a health care facility, a licensed home health agency, a licensed
clinic in which there is a physician oversight, a provider who
contracts with a licensed health care service plan with regard to the
care or services provided to the enrollees of that health care
service plan, or a physician, as authorized by Section 4052.2.
(6) Perform procedures or functions as authorized by Section
4052.6.
(7) Manufacture, measure, fit to the patient, or sell and repair
dangerous devices, or furnish instructions to the patient or the
patient's representative concerning the use of those devices.
(8) Provide consultation, training, and education to patients
about drug therapy, disease management, and disease prevention.
(9) Provide professional information, including clinical or
pharmacological information, advice, or consultation to other health
care professionals, and participate in multidisciplinary review of
patient progress, including appropriate access to medical records.
(10) Furnish the following medications:
(A) Emergency contraception drug therapy and self-administered
hormonal contraceptives, as authorized by Section 4052.3.
(B) Prescription smoking cessation drugs and devices, as
authorized by Section 4052.9.
(C) Prescription medications not requiring a diagnosis that are
recommended by the federal Centers for Disease Control and Prevention
for individuals traveling outside of the United States.
(11) Administer immunizations pursuant to a protocol with a
prescriber.
(12) Order and interpret tests for the purpose of monitoring and
managing the efficacy and toxicity of drug therapies.
(b) A pharmacist who is authorized to issue an order to initiate
or adjust a controlled substance therapy pursuant to this section
shall personally register with the federal Drug Enforcement
Administration.
(c) This section does not affect the applicable requirements of
law relating to either of the following:
(1) Maintaining the confidentiality of medical records.
(2) The licensing of a health care facility.
SEC. 6. Section 4052.3 of the Business and Professions Code is
amended to read:
4052.3. (a) (1) Notwithstanding any other law, a pharmacist may
furnish self-administered hormonal contraceptives in accordance with
standardized procedures or protocols developed and approved by both
the board and the Medical Board of California in consultation with
the American Congress of Obstetricians and Gynecologists, the
California Pharmacists Association, and other appropriate entities.
The standardized procedure or protocol shall require that the patient
use a self-screening tool, based on the United States Medical
Eligibility Criteria (USMEC) for Contraceptive Use developed by the
federal Centers for Disease Control and Prevention, and that the
pharmacist refer the patient to the patient's primary care provider
or, if the patient does not have a primary care provider, to nearby
clinics.
(2) The board and the Medical Board of California are both
authorized to ensure compliance with this subdivision, and each board
is specifically charged with the enforcement of this subdivision
with respect to its respective licensees. This subdivision does not
expand the authority of a pharmacist to prescribe any prescription
medication.
(b) (1) Notwithstanding any other law, a pharmacist may furnish
emergency contraception drug therapy in accordance with either of the
following:
(A) Standardized procedures or protocols developed by the
pharmacist and an authorized prescriber who is acting within his or
her scope of practice.
(B) Standardized procedures or protocols developed and approved by
both the board and the Medical Board of California in consultation
with the American Congress of Obstetricians and Gynecologists, the
California Pharmacists Association, and other appropriate entities.
The board and the Medical Board of California are both authorized to
ensure compliance with this clause, and each board is specifically
charged with the enforcement of this provision with respect to its
respective licensees. This subdivision does not expand the authority
of a pharmacist to prescribe any prescription medication.
(2) Prior to performing a procedure authorized under this
subdivision, a pharmacist shall complete a training program on
emergency contraception that consists of at least one hour of
approved continuing education on emergency contraception drug
therapy.
(3) A pharmacist, pharmacist's employer, or pharmacist's agent
shall not directly charge a patient a separate consultation fee for
emergency contraception drug therapy services initiated pursuant to
this subdivision, but may charge an administrative fee not to exceed
ten dollars ($10) above the retail cost of the drug. Upon an oral,
telephonic, electronic, or written request from a patient or
customer, a pharmacist or pharmacist's employee shall disclose the
total retail price that a consumer would pay for emergency
contraception drug therapy. As used in this paragraph, total retail
price includes providing the consumer with specific information
regarding the price of the emergency contraception drugs and the
price of the administrative fee charged. This limitation is not
intended to interfere with other contractually agreed-upon terms
between a pharmacist, a pharmacist's employer, or a pharmacist's
agent, and a health care service plan or insurer. Patients who are
insured or covered and receive a pharmacy benefit that covers the
cost of emergency contraception shall not be required to pay an
administrative fee. These patients shall be required to pay
copayments pursuant to the terms and conditions of their coverage.
This paragraph shall become inoperative for dedicated emergency
contraception drugs if these drugs are reclassified as
over-the-counter products by the federal Food and Drug
Administration.
(4) A pharmacist shall not require a patient to provide
individually identifiable medical information that is not specified
in Section 1707.1 of Title 16 of the California Code of Regulations
before initiating emergency contraception drug therapy pursuant to
this subdivision.
(c) For each emergency contraception drug therapy or
self-administered hormonal contraception initiated pursuant to this
section, the pharmacist shall provide the recipient of the drug with
a standardized factsheet that includes, but is not limited to, the
indications and contraindications for use of the drug, the
appropriate method for using the drug, the need for medical followup,
and other appropriate information. The board shall develop this form
in consultation with the State Department of Public Health, the
American Congress of Obstetricians and Gynecologists, the California
Pharmacists Association, and other health care organizations. This
section does not preclude the use of existing publications developed
by nationally recognized medical organizations.
SEC. 7. Section 4052.6 is added to the Business and Professions
Code, to read:
4052.6. (a) A pharmacist recognized by the board as an advanced
practice pharmacist may do all of the following:
(1) Perform patient assessments.
(2) Order and interpret drug therapy-related tests.
(3) Refer patients to other health care providers.
(4) Participate in the evaluation and management of diseases and
health conditions in collaboration with other health care providers.
(5) Initiate, adjust, or discontinue drug therapy in the manner
specified in paragraph (4) of subdivision (a) of Section 4052.2.
(b) A pharmacist who adjusts or discontinues drug therapy shall
promptly transmit written notification to the patient's diagnosing
prescriber or enter the appropriate information in a patient record
system shared with the prescriber. A pharmacist who initiates drug
therapy shall promptly transmit written notification to, or enter the
appropriate information into, a patient record system shared with
the patient's primary care provider or diagnosing provider, as
appropriate.
(c) This section shall not interfere with a physician's order to
dispense a prescription drug as written, or other order of similar
meaning.
(d) Prior to initiating or adjusting a controlled substance
therapy pursuant to this section, a pharmacist shall personally
register with the federal Drug Enforcement Administration.
SEC. 8. Section 4052.8 is added to the Business and Professions
Code, to read:
4052.8. (a) In addition to the authority provided in paragraph
(9) of subdivision (a) of Section 4052, a pharmacist may
independently initiate and administer vaccines listed on the routine
immunization schedules recommended by the federal Advisory Committee
on Immunization Practices (ACIP), in compliance with individual ACIP
vaccine recommendations, and published by the federal Centers for
Disease Control and Prevention (CDC) for persons three years of age
and older.
(b) In order to initiate and administer an immunization described
in subdivision (a), a pharmacist shall do all of the following:
(1) Complete an immunization training program endorsed by the CDC
or the Accreditation Council for Pharmacy Education that, at a
minimum, includes hands-on injection technique, clinical evaluation
of indications and contraindications of vaccines, and the recognition
and treatment of emergency reactions to vaccines, and shall maintain
that training.
(2) Be certified in basic life support.
(3) Comply with all state and federal recordkeeping and reporting
requirements, including providing documentation to the patient's
primary care provider and entering information in the appropriate
immunization registry designated by the immunization branch of the
State Department of Public Health.
(c) A pharmacist administering immunizations pursuant to this
section, or paragraph (9) of subdivision (a) of Section 4052, may
also initiate and administer epinephrine or diphenhydramine by
injection for the treatment of a severe allergic reaction.
SEC. 9. Section 4052.9 is added to the Business and Professions
Code, to read:
4052.9. A pharmacist may furnish prescription smoking cessation
drugs and devices, and provide smoking cessation services if all of
the following conditions are met:
(a) The pharmacist maintains records of all prescription drugs and
devices furnished for a period of at least three years for purposes
of notifying other health care providers and monitoring the patient.
(b) The pharmacist notifies the patient's primary care provider of
any drugs or devices furnished to the patient. If the patient does
not have a primary care provider, the pharmacist provides the patient
with a written record of the drugs or devices furnished and advises
the patient to consult a physician of the patient's choice.
(c) The pharmacist is certified in smoking cessation therapy by an
organization recognized by the board.
(d) The pharmacist completes one hour of continuing education
focused on smoking cessation therapy biennially.
(e) The pharmacist shall consult with the patient's primary care
provider before furnishing a smoking cessation drug to the patient
that may produce serious neuropsychiatric events.
SEC. 10. Section 4060 of the Business and Professions Code is
amended to read:
4060. A person shall not possess any controlled substance, except
that furnished to a person upon the prescription of a physician,
dentist, podiatrist, optometrist, veterinarian, or naturopathic
doctor pursuant to Section 3640.7, or furnished pursuant to a drug
order issued by a certified nurse-midwife pursuant to Section
2746.51, a nurse practitioner pursuant to Section 2836.1, a physician
assistant pursuant to Section 3502.1, a naturopathic doctor pursuant
to Section 3640.5, or a pharmacist pursuant to Section 4052.1,
4052.2, or 4052.6. This section does not apply to the possession of
any controlled substance by a manufacturer, wholesaler, pharmacy,
pharmacist, physician, podiatrist, dentist, optometrist,
veterinarian, naturopathic doctor, certified nurse-midwife, nurse
practitioner, or physician assistant, if in stock in containers
correctly labeled with the name and address of the supplier or
producer.
This section does not authorize a certified nurse-midwife, a nurse
practitioner, a physician assistant, or a naturopathic doctor, to
order his or her own stock of dangerous drugs and devices.
SEC. 11. Section 4210 is added to the Business and Professions
Code, to read:
4210. (a) A person who seeks recognition as an advanced practice
pharmacist shall meet all of the following requirements:
(1) Hold an active license to practice pharmacy issued pursuant to
this chapter that is in good standing.
(2) Satisfy any two of the following criteria:
(A) Earn certification in a relevant area of practice, including,
but not limited to, ambulatory care, critical care, nuclear pharmacy,
nutrition support pharmacy, oncology pharmacy, pediatric pharmacy,
pharmacotherapy, or psychiatric pharmacy, from an organization
recognized by the Accreditation Council for Pharmacy Education or
another entity recognized by the board.
(B) Complete a one-year postgraduate residency through an
accredited postgraduate institution where at least 50 percent of the
experience includes the provision of direct patient care services
with interdisciplinary teams.
(C) Have actively managed patients for at least one year under a
collaborative practice agreement or protocol with a physician,
advanced practice pharmacist, pharmacist practicing collaborative
drug therapy management, or health system.
(3) File an application with the board for recognition as an
advanced practice pharmacist.
(4) Pay the applicable fee to the board.
(b) An advanced practice pharmacist recognition issued pursuant to
this section shall be valid for two years, coterminous with the
certificate holder's license to practice pharmacy.
(c) The board shall adopt regulations establishing the means of
documenting completion of the requirements in this section.
(d) The board shall, by regulation, set the fee for the issuance
and renewal of advanced practice pharmacist recognition at the
reasonable cost of regulating advanced practice pharmacists pursuant
to this chapter. The fee shall not exceed three hundred dollars
($300).
SEC. 12. Section 4233 is added to the Business and Professions
Code, to read:
4233. A pharmacist who is recognized as an advanced practice
pharmacist shall complete 10 hours of continuing education each
renewal cycle in addition to the requirements of Section 4231. The
subject matter shall be in one or more areas of practice relevant to
the pharmacist's clinical practice.
SEC. 13. No reimbursement is required by this act pursuant to
Section 6 of Article XIII B of the California Constitution because
the only costs that may be incurred by a local agency or school
district will be incurred because this act creates a new crime or
infraction, eliminates a crime or infraction, or changes the penalty
for a crime or infraction, within the meaning of Section 17556 of the
Government Code, or changes the definition of a crime within the
meaning of Section 6 of Article XIII B of the California
Constitution.